Tiotropium Bromide hydrate

CAS No. 139404-48-1

Tiotropium Bromide hydrate ( BA-679 BR hydrate )

Catalog No. M17275 CAS No. 139404-48-1

Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 Get Quote
10MG 78 Get Quote
25MG 141 Get Quote
50MG 176 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tiotropium Bromide hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
  • Description
    Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
  • Synonyms
    BA-679 BR hydrate
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    AChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    139404-48-1
  • Formula Weight
    490.43
  • Molecular Formula
    C19H22NO4S2·Br·xH2O
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    O.[Br-].[H][C@]12C[C@@H](C[C@]([H])([C@H]3O[C@@H]13)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Barnes PJ, et al. Life Sci, 1995, 56(11-12), 853-859.
molnova catalog
related products
  • BI-4020

    BI-4020 is a fourth-generation, non-covalent, and orally active inhibitor of EGFR tyrosine kinase.

  • AZ7550

    AZ7550 is an active metabolite of AZD9291 and inhibits the activity of IGF1R with an IC50 of 1.6 μM.

  • Lapatinib

    A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.